USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation

Sunbin Ling, Qiaonan Shan, Qifan Zhan, +22

Gut

Mice Bearing HccCancer BiologyRedox BiologyTumor BiologyTranscriptional Regulation +22

Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy

Shengjun Xu, Sunbin Ling, Qiaonan Shan, +14

Advanced Science

Drug TargetingCancer StemnessNovel TherapyHcc StemnessMedicine +12

Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: insights into apoptosis, autophagy, ferroptosis, and pyroptosis

Cong Chen, Jian Liu, Xia Lin, +6

Cell Death Discovery

Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma

Zhikun Liu, Qianwei Ye, Lingjiao Wu, +5

Molecular Carcinogenesis

ImmunologyPathologyTumor BiologyOncologyHepatobiliary Tumor +14

High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma

Xuanyu Zhang, Runzhou Zhuang, Qianwei Ye, +7

Journal of Cancer

Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China

Qifan Zhan, Sunbin Ling, Yinan Deng, +16

Hepatobiliary & pancreatic diseases international

HepatologyMedicineHistopathologyHangzhou CriteriaPathology +6

E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation

Sunbin Ling, Qifan Zhan, Guangjiang Jiang, +21

American Journal of Transplantation

HepatologyRapamycin Inhibitor ResistanceMedicinePathologyLiver Cancer +5

“Sweet tooth”-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy

Ning Ding, Shengjun Xu, Sheng Zheng, +10

Journal of Materials Chemistry B

NanotherapeuticsEngineeringGlycobiologyGastric Cancer TherapyNanomedicine +17

Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria

Sunbin Ling, Tingting Feng, Qifan Zhan, +10

Annals of Translational Medicine

Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria

Qianwei Ye, Sunbin Ling, Guangjiang Jiang, +7

European Journal of Surgical Oncology

HepatologyMedicineImmunologyImmune Checkpoint InhibitorLiver Cancer +7